Form 4: Palisade Bio Director Donald Williams Buys 1,000 Shares

Director Donald Williams of Palisade Bio, Inc. (PALI) purchased 1,000 shares of common stock at $4.863 per share on May 28, 2024.

Summary

• On May 28, 2024, Donald Allen Williams, a director of Palisade Bio, Inc. (PALI), purchased 1,000 shares of the company's common stock.
• The purchase price was $4.863 per share.
• Following the transaction, Williams directly owns 1,000 shares and indirectly owns 2,000 shares through a defined benefit plan.

Sentiment

Score: 6

Explanation: Neutral sentiment. It's a routine disclosure of a stock purchase by a director. While insider buying can be seen as a positive signal, it's a relatively small transaction and doesn't necessarily indicate a major shift in the company's outlook.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This is a routine disclosure of insider trading activity. It's common for directors and officers of publicly traded companies to buy and sell shares of their company's stock. These transactions are closely monitored and regulated by the SEC to prevent insider trading.

Stakeholder Impact

• The stock purchase could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Palisade Bio, PALI, Donald Williams, stock purchase, director, Form 4, beneficial ownership